Tff Current Deferred Revenue vs Net Debt Analysis
TFFP Stock | USD 2.06 0.01 0.49% |
Tff Pharmaceuticals financial indicator trend analysis is much more than just breaking down Tff Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tff Pharmaceuticals is a good investment. Please check the relationship between Tff Pharmaceuticals Current Deferred Revenue and its Net Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tff Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.
Current Deferred Revenue vs Net Debt
Current Deferred Revenue vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tff Pharmaceuticals Current Deferred Revenue account and Net Debt. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Tff Pharmaceuticals' Current Deferred Revenue and Net Debt is 0.11. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Net Debt in the same time period over historical financial statements of Tff Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Tff Pharmaceuticals' Current Deferred Revenue and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Tff Pharmaceuticals are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Current Deferred Revenue i.e., Tff Pharmaceuticals' Current Deferred Revenue and Net Debt go up and down completely randomly.
Correlation Coefficient | 0.11 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most indicators from Tff Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tff Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tff Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.As of 06/01/2024, Selling General Administrative is likely to drop to about 6.8 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 4.8 M
Tff Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Tff Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tff Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Current Liabilities | 410.6K | 1.3M | 2.0M | 1.1M | 2.4M | 2.5M | |
Total Stockholder Equity | 27.6M | 37.3M | 38.7M | 22.9M | 9.6M | 9.1M | |
Net Tangible Assets | (3.2M) | 27.6M | 37.3M | 38.7M | 44.5M | 46.8M | |
Retained Earnings | (15.7M) | (34.3M) | (65.3M) | (97.1M) | (118.3M) | (112.4M) | |
Accounts Payable | 410.6K | 1.3M | 1.5M | 919.6K | 958.4K | 759.2K | |
Total Liab | 1.5M | 1.3M | 2.0M | 1.2M | 2.5M | 1.3M | |
Total Assets | 29.2M | 38.7M | 40.7M | 24.1M | 12.0M | 11.4M | |
Cash | 28.1M | 35.3M | 33.8M | 16.6M | 5.5M | 5.2M | |
Common Stock Shares Outstanding | 276.2K | 817.0K | 992.8K | 1.2M | 1.8M | 1.7M | |
Non Current Liabilities Total | 1.1M | 1.3M | 416.9K | 110.1K | 31.7K | 30.2K | |
Net Invested Capital | 27.6M | 37.3M | 38.7M | 22.9M | 9.6M | 9.1M | |
Total Current Assets | 29.2M | 37.6M | 38.8M | 19.0M | 7.6M | 7.2M | |
Net Working Capital | 28.8M | 36.2M | 36.9M | 17.9M | 5.2M | 4.9M | |
Net Debt | (28.1M) | (35.3M) | (33.8M) | (16.4M) | (5.4M) | (5.6M) | |
Cash And Short Term Investments | 28.1M | 35.3M | 33.8M | 16.6M | 5.5M | 5.2M | |
Liabilities And Stockholders Equity | 29.2M | 38.7M | 40.7M | 24.1M | 12.0M | 20.7M | |
Other Current Assets | 1.1M | 2.3M | 2.4M | 2.2M | 1.7M | 1.8M | |
Other Stockholder Equity | 43.3M | 71.6M | 104.1M | 120.1M | 128.0M | 88.0M | |
Accumulated Other Comprehensive Income | (29.2M) | (51.5K) | (48.9K) | (139.3K) | (148.2K) | (155.6K) | |
Capital Stock | 18.5K | 22.5K | 25.4K | 36.2K | 2.4K | 2.3K | |
Common Stock | 18.5K | 22.5K | 25.4K | 36.2K | 2.4K | 2.3K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Tff Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.Note that the Tff Pharmaceuticals information on this page should be used as a complementary analysis to other Tff Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Tff Stock analysis
When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Tff Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tff Pharmaceuticals. If investors know Tff will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tff Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.38) | Revenue Per Share 0.409 | Quarterly Revenue Growth (0.63) | Return On Assets (0.76) | Return On Equity (1.31) |
The market value of Tff Pharmaceuticals is measured differently than its book value, which is the value of Tff that is recorded on the company's balance sheet. Investors also form their own opinion of Tff Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Tff Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tff Pharmaceuticals' market value can be influenced by many factors that don't directly affect Tff Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tff Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tff Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tff Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.